Intrua Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $382K | Buy |
+15,681
| New | +$382K | 0.05% | 251 |
|
|
2024
Q3 | – | Sell |
-9,761
| Closed | -$229K | – | 381 |
|
|
2024
Q2 | $229K | Sell |
9,761
-1,248
| -11% | -$29.3K | 0.03% | 354 |
|
|
2024
Q1 | $317K | Sell |
11,009
-1,168
| -10% | -$33.6K | 0.05% | 309 |
|
|
2023
Q4 | $400K | Sell |
12,177
-2,958
| -20% | -$97.1K | 0.06% | 260 |
|
|
2023
Q3 | $422K | Sell |
15,135
-2,049
| -12% | -$57.1K | 0.07% | 218 |
|
|
2023
Q2 | $586K | Sell |
17,184
-1,901
| -10% | -$64.8K | 0.1% | 174 |
|
|
2023
Q1 | $570K | Sell |
19,085
-3,789
| -17% | -$113K | 0.12% | 164 |
|
|
2022
Q4 | $727K | Sell |
22,874
-3,355
| -13% | -$107K | 0.17% | 134 |
|
|
2022
Q3 | $862K | Sell |
26,229
-4,162
| -14% | -$137K | 0.23% | 100 |
|
|
2022
Q2 | $957K | Sell |
30,391
-1,574
| -5% | -$49.6K | 0.2% | 112 |
|
|
2022
Q1 | $1.47M | Sell |
31,965
-3,476
| -10% | -$160K | 0.26% | 78 |
|
|
2021
Q4 | $2.17M | Sell |
35,441
-3,506
| -9% | -$215K | 0.38% | 53 |
|
|
2021
Q3 | $2.88M | Buy |
38,947
+898
| +2% | +$66.5K | 0.53% | 36 |
|
|
2021
Q2 | $3.18M | Buy |
38,049
+674
| +2% | +$56.3K | 0.76% | 26 |
|
|
2021
Q1 | $3.44M | Buy |
37,375
+21,680
| +138% | +$2M | 0.87% | 23 |
|
|
2020
Q4 | $1.46M | Buy |
15,695
+2,020
| +15% | +$188K | 0.65% | 28 |
|
|
2020
Q3 | $1.01M | Buy |
13,675
+6,284
| +85% | +$465K | 0.5% | 43 |
|
|
2020
Q2 | $439K | Buy |
+7,391
| New | +$439K | 0.17% | 124 |
|